Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Elizabeth Winters

1PUBLICATIONS

12CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 20, 2025

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

Pageof 1

Frequent Collaborators

1 joint publications

A Dimitrios Colevas

1 joint publications

Zahra Talebi

1 joint publications

Caroline Even

1 joint publications

Victor Ho-Fun Lee

1 joint publications

Maura L Gillison

1 joint publications

Saad A Khan

1 joint publications

Rong Lu

1 joint publications

Benjamin A Pinsky

1 joint publications

Samantha S Soldan

1 joint publications

Olga Vladmirova

Frequent Collaborators

1 joint publications

A Dimitrios Colevas

1 joint publications

Zahra Talebi

1 joint publications

Caroline Even

1 joint publications

Victor Ho-Fun Lee

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

See more related videos

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

See more related videos